Reed Smith LLP, in conjunction with ChemRisk and the Center for Business Intelligence, is presenting a complimentary webinar, “Nanotechnology – What the Life Sciences Industry Needs to Know about Managing its Risks”, October 22 at noon eastern.
The moderator for this event will be Reed Smith partner Antony B. Klapper. Speakers include:
- Barr Weiner, Associate Director for Policy in the Food and Drug Administration’s Office of Combination Products and the OCP representative on the FDA’s agency-wide Nanotechnology Task Force
- Leonard I. Sweet, Senior Health Scientist, ChemRisk, Inc.
- Amy K. Madl, Senior Managing Health Scientist, ChemRisk, Inc.
The program will last one hour and will provide an overview of nanotechnology and its uses in the life sciences industry; actual and theoretical risks posed to humans by the use of engineered nanomaterials; the ways that life sciences companies can evaluate those potential risks and mitigate them through risk management practices and good product stewardship; and legal risks associated with engineered nanomaterials, and exploring next steps at the FDA and other regulatory bodies.
